Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats
- 10 August 2010
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 639 (1-3), 67-80
- https://doi.org/10.1016/j.ejphar.2009.12.040
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Increased impulsivity and disrupted attention induced by repeated phencyclidine are not attenuated by chronic quetiapine treatmentPharmacology Biochemistry and Behavior, 2009
- Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administrationPsychopharmacology, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time taskNeuropharmacology, 2007
- Abnormal Kainate Receptor Expression in Prefrontal Cortex in SchizophreniaNeuropsychopharmacology, 2001
- LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsNeuropharmacology, 1998
- Systemic phencyclidine administration is associated with increased dopamine, GABA, and 5-HIAA levels in the dorsolateral striatum of conscious rats: an in vivo microdialysis studyJournal of Neural Transmission, 1994
- In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized ratsActa Physiologica Scandinavica, 1994
- Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysisNeuroscience Letters, 1992
- Treatment of schizophreniaProgress in Neuro-Psychopharmacology, 1979